This group encompasses substances that promote oxygen delivery, muscle repair, and recovery, such as erythropoiesis-stimulating agents, growth hormones and analogues, and growth factor mimetics and releasing agents
The last 5 years have seen the emergence of efficacious peptide-based therapies for obesity treatment that target glucagon-like peptide-1 receptor (GLP-1R), either selectively or via co-activation with related receptors, such as the glucose-dependent insulinotropic polypeptide and/or glucagon receptors 1
As an investigational peptide with extensive clinical trial data, it offers researchers a well-characterized tool for studying amylin receptor biology [18]
Combining cagrilintide with tirzepatide could theoretically produce 20-30% body weight loss by targeting three distinct pathways (GIP, GLP-1, and amylin), but the lack of clinical data means dosing protocols are speculative, side effect profiles unknown, and safety unclear
Just finished my first bottle